If oral formulations result in higher persistence rates, the cost-per-outcome calculation improves significantly
Early signals may appear first: appetite, satiety, nausea, bowel-pattern changes, and scale movement can show up before the formal trial endpoints, especially during dose escalation
10.3390/nano10112172 Nanomaterials Summary Keywords RNA therapeutics, delivery of RNA therapeutics, hospital-based RNA therapeutics, messenger RNAs (mRNAs), self-amplifying mRNA Citation Damase TR, Sukhovershin R, Boada C, Taraballi F, Pettigrew RI and Cooke JP (2021) The Limitless Future of RNA Therapeutics
This formulation allows the solution to remain usable for multiple withdrawals over a defined period when handled properly under aseptic laboratory conditions
It is also sometimes called a labial lentigo and when multiple lesions are present, mucosal melanosis